HomeOKUR • NASDAQ
add
Onkure Therapeutics Inc
Previous close
$2.06
Day range
$2.00 - $2.22
Year range
$1.70 - $19.60
Market cap
27.02M USD
Avg Volume
188.93K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 17.00M | 72.92% |
Net income | -15.92M | -67.00% |
Net profit margin | — | — |
Earnings per share | -1.19 | — |
EBITDA | -16.89M | -73.77% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 96.66M | 402.19% |
Total assets | 99.88M | 307.23% |
Total liabilities | 9.23M | 54.85% |
Total equity | 90.65M | — |
Shares outstanding | 13.44M | — |
Price to book | 0.31 | — |
Return on assets | -39.57% | — |
Return on capital | -43.25% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -15.92M | -67.00% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2011
Headquarters
Website
Employees
46
